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Background. Studies have shown that women are more likely to have irritable bowel syndrome (IBS) and more women seek
healthcare because of IBS than men. Aim. We wanted to examine the natural history of IBS and dysmenorrhea in women over
a 10-year period and to assess the change in IBS after menopause. Method. A population-based postal study. A questionnaire was
mailed to the same age- and gender-stratified random sample of the Icelandic population aged 18–75 in 1996 and again in 2006.
Results. 77% premenopausal women had dysmenorrhea in the year 1996 and 74% in 2006. 42% of women with dysmenorrhea
had IBS according to Manning criteria in the year 2006 and 49% in 1996. 26% of women with dysmenorrhea had IBS according
to Rome III 2006 and 11% in the year 1996. In 2006 30% women had severe or very severe dysmenorrhea pain severity. More
women (27%) reported severe abdominal pain after menopause than before menopause 11%. Women without dysmenorrhea
were twice more likely to remain asymptomatic than the women with dysmenorrhea. Women with dysmenorrhea were more
likely to have stable symptoms and were twice more likely to have increased symptoms. Conclusion. Women with IBS are more
likely to experience dysmenorrhea than women without IBS which seems to be a part of the symptomatology in most women with
IBS. IBS symptom severity seems to increase after menopause.
1. Introduction
Irritable bowel syndrome (IBS) is a functional bowel disorder
in which abdominal pain or discomfort is associated with
defecation or a change in bowel habits and with features
of disordered defecation [1]. Patients often experience addi-
tional symptoms such as bloating, sensation of incomplete
evacuation, straining (constipation), and urgency (diarrhea)
[2]. In the Western countries, more women than men
seek health-care services for irritable bowel syndrome (IBS)
[3, 4]. This can possibly be explained by factors involving
physiological gender diﬀerences in gonadal hormones, stress
reactivity, and inflammatory responses, as well as sociocul-
tural diﬀerences in response to pain and/or bowel pattern
changes [4]. In a recent study of men and women with IBS,
the gender diﬀerences found were more complicated than a
simple ration of men:women [5]. Women with IBS report
more constipation, nausea, bloating, and extraintestinal and
psychological symptoms than men with IBS [6]. Gender-
related diﬀerences in gastrointestinal and somatic symptoms
are apparent in persons with IBS but are most prominent
in postmenopausal women [7]. Abdominal pain has been
shown to be the most disruptive symptom in IBS and impacts
on the quality of life in women with IBS [8]. The diﬀerences
between genders in the occurrence of IBS could furthermore
be the result of cultural, psychosocial, or healthcare access
issues instead of purely physiologic diﬀerences [9].
Dysmenorrhea is a common conditions that can occur
in 50–90% of women [10]. Dysmenorrhea is one of the
most common complaints among women. It is defined
as the presence of menstruation-associated spasmodic pain
in the abdomen. Dysmenorrhea, dyspareunia, pelvic pain,
and irritable bowel syndrome are common complaints
among women of reproductive age and are not consistently
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associated with demographic risk factors [11]. Many women
experience discomfort at the time of their periods. For most,
this does not interfere with their daily lives or requires any
special attention. However, for some women their monthly
period is painful, problematic, and in some cases disabling.
It can interfere with their lives because of the pain and
inconvenience caused.
Dysmenorrhea severe enough to cause absence from
work occurs in less than 5% of women [10]. Although
improvement and worsening are equally likely for all women,
improvement is more likely in women who bear children
[10].
Population-based studies are essential for studying IBS
since only a minority of IBS patients seek medical care [12].
Self-medication is common among these patients [12], and
diﬀerences have been noted in IBS patients and nonpatients
from the community [13, 14]. The great majority of IBS
studies are patient or healthcare based. Women overall
have a greater prevalence of IBS symptoms than men,
particularly those associated with constipation [15]. Studies
suggest that female sex hormones influence the severity
of IBS symptoms [15]. A recent study suggests that an
increase in gastrointestinal symptoms around the time of
menses and early menopause occurs at times of declining
or low ovarian hormones, suggesting that estrogen and
progesterone withdrawal may contribute either directly or
indirectly [16].
The objective of our study was to study the connection
of IBS and dysmenorrhea in women and the change over
a 10-year period. The secondary objective was to assess
the change in IBS over menopause and the birth cohort
eﬀect of dysmenorrhea. The third objective was to assess the
connection of functional gastrointestinal disorders (FGIDs)
including functional dyspepsia (FD), heartburn and frequent
abdominal pain (FAP), and dysmenorrhea severity.
2. Methods
2.1. Participants and Setting. In 1996 an epidemiological
study of gastrointestinal diseases was performed in Iceland
[17]. Involved were 2000 inhabitants in the age range of
18–75 years. The individuals were randomly selected from
the National Registry. Equal distribution of sex and age was
secured in each age group. In 2006 we attempted to contact
all the individuals from 1996. A questionnaire was mailed to
individuals at baseline, and the study questionnaire and an
explanatory letter mailed to all eligible individuals. Reminder
letters were mailed at 2, 4, and 7 weeks, using the Total
Method of Dillman [18]. Individuals who indicated at any
point that they did not want to participate in the study were
not contacted further.
2.2. The Questionnaire. The bowel disease questionnaire
(BDQ) [19, 20] was translated from English into Icelandic
and modified for this study. The questionnaire was translated
by two gastroenterologists and a pharmacist. A specialist in
the Icelandic language at the University of Iceland made a lin-
guistic modification. The questionnaire was piloted within a
small group of IBS patients diagnosed by gastroenterologist.
The questionnaire was designed as a self-report instru-
ment to measure symptoms experienced over the previous
year and to collect the participant’s past medical history [21].
The Icelandic version of the BDQ questionnaire
addressed 47 gastrointestinal symptoms and 32 items that
measure past illness, health care use, and socio-demographic
and psychosomatic symptoms, together with a valid measure
of non-GI somatic complaints, the somatic symptom check-
list (SSC) [22]. There were only a few changes in the latter
questionnaire (2006) which addressed 51 gastrointestinal
symptoms and 33 items that measure past illness, health care
use, and socio-demographic and psychosomatic symptoms.
The questionnaire included questions on dysmenorrhea and
the pain severity of dysmenorrhea.
2.3. Criteria to Identify Dysmenorrhea. Women were asked if
they had menstruation. If they were menstruating, they were
asked if they experienced dysmenorrhea in the beginning
of their menstruation. Those who had dysmenorrhea were
asked to state the magnitude of the dysmenorrhea pain;
minor pain, medium pain, severe pain, very severe pain,
and no pain. Menopause was identified in women who
were menstruating in 1996 but reported that they did not
menstruate in 2006.
2.4. Criteria to Identify IBS. The criteria for identification of
IBS are presented in Table 1.
Diagnosis of IBS according to the Manning criteria [23]
required two or more of the six symptoms listed in Table 1
and abdominal pain six or more times during the previous
year [24, 25].
2.5. Transition between Disorders from the Initial to the
Final Survey. A transition model used by Halder et al. was
modified and applied for this study [21]. The responses from
the initial (1996) and final (2006) surveys were matched for
each subject to examine the changes between disorders at
an individual level for the 6 categories (IBS, FD, heartburn,
frequent abdominal pain, and no symptoms). A 5 × 5 table
was used to model these multiple changes and collapsed into
6 groups, as illustrated in Figure 1. Those with the most
symptoms were prioritized higher. Those who developed
more symptoms and those who reported fewer symptoms
could be categorised into groups. There were six patterns
of symptoms, identified as follows: (1) symptom stability,
(2) symptom increase, (3) symptom decrease, (4) symptom
onset, (5) becoming asymptomatic, and (6) none of these
symptoms.
2.6. Mortality Data. For the 2006 survey, we identified all
deceased individuals with the assistance of the National
Registry of Iceland.
2.7. Statistical Analysis. Tables were constructed for fre-
quency and percentage. Categorical variables were summa-
rized using frequency and percentage. Chi square test was
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Figure 1: Transitions among symptom subgroups between the initial and final surveys. Women with dysmenorrhea, women without
dysmenorrhea.
used to compare categorical variable. Type I error protection
rate was set at 0.05. The exact P is listed in the tables and text.
The statistical software SPSS (Statistical Package of Social
Science) was used for data analysis.
2.8. Ethics. The National Bioethics Committee of Iceland
and The Icelandic Data Protection Authority gave their
permission for the research.
3. Results
3.1. Demographic Data of Involved Individuals. In 1996
the response rate was 66.8% (1336/2000). Of the 1336
individuals who participated in 1996, 81 were deceased by
2006, five subjects were unable to answer, mainly because of
old age, and 70 could not be traced to a current address.
This left 1180 individuals, out of which 799 responded
in 2006 (Figure 2). The response rate in 2006 was 63.7%
(799/1255). The mean age of the individuals in 1996 was
43 and in 2006 53; there was not a significant diﬀerence
between those who responded 2006 and those who did not
respond (NS). Women were more apt to respond than men
in both years. A larger proportion of women responded
again in 2006 (57.8%) than those who responded in 1996
but did not respond again in 2006 (49.8%, P < 0.01).
The responders represented the population concerning sex
and age distribution. The response rate was higher for
older subjects than younger ones. There was no significant
diﬀerence between those who responded or those who did
not respond in the year 2006, whether they were diagnosed
with IBS in the year 1996 or not. Age distribution and
demographic details of the study cohort are presented in
Table 2.
3.2. Dysmenorrhea (Painful Menstruation). Of those women
who responded, 331 women reported menstruation in 1996
and 205 in the year 2006. A total of 254/331 (77%) in
1996 and 152/205 (74%) in 2006 reported dysmenorrhea
(Table 3). Half of those reported medium severity of dysmen-
orrhea. Slightly more reported minor dysmenorrhea in the
year 1996 than 2006. Slightly more reported severe or very
severe dysmenorrhea (Figure 3).
3.3. Dysmenorrhea and Irritable Bowel Syndrome. One out
of ten women with dysmenorrhea had IBS according to the
Rome III criteria in the year 1996, and 5% of women without
dysmenorrhea had IBS (P = 0.170) (Table 4). A total of
39/152 (26%) women with dysmenorrhea had IBS according
to Rome III in the year 2006 and 14/152 (9%) of women
without dysmenorrhea had IBS, with a statistical diﬀerence
(P = 0.013).
Overall 105/254 (41.5%) of women with dysmenorrhea
had IBS according to the Manning criteria in the year 1996,
and one out of four without dysmenorrhea had IBS, with a
statistical diﬀerence (P = 0.014). 49% of the women in the
year 2006 of women with dysmenorrhea had IBS according
to Manning and 33% of women without dysmenorrhea had
IBS in the year 2006 (P = 0.063).
4 Gastroenterology Research and Practice
Table 1: Criteria to identify IBS.
Manning
Pain eased after BM
Looser stools at onset of pain
More frequent BM at onset of pain
Abdominal distension
Mucus per rectum
Feeling of incomplete emptying
Rome III criteria
Recurrent abdominal pain or discomfort at least 3 days/month
in the last 3 months association with two or more of the following:
Improvement with defecation
Onset associated with a change in frequency of stool
Onset associated with a change in form (appearance) of stool
BMs, bowel movements.
Subgroups of Rome III: subjects fulfilling the Rome III criteria
were divided into 4 subgroups according to their bowel habits:
(1) diarrhea-predominant (IBS-D), IBS-D is determined by
predominantly loose or watery stools ≥25% of the time
(2) constipation- predominant (IBS-C), IBS-C is determined
by predominantly hard or lumpy stools ≥25% of the time
(3) diarrhea and constipation (IBS-M), categories for mixed
(mixed irritable bowel syndrome (IBS-M): meeting criteria
for IBS-D and IBS-C ≥25% of time)
(4) no diarrhea or constipation, un-subtyped (un-subtyped
irritable bowel syndrome (IBS-U): not meeting criteria for
of IBS-C nor IBS-D, that is, both are <25% of the time).
Rome III: a close approximation of the Rome III criteria was used. The data
were reevaluated retrospectively to conform to the Rome III criteria.
Table 2: Study population. Age and sex distribution.
Population 2006 (%) Respondents 2006 (%)
Gender
Men 50.3 42.2
Women 49.7 57.8
Age
28–35 19.5 14.52
36–45 24.9 20.40
46–55 22.8 22.15
56–65 15.6 19.52
66–75 10.4 15.14
76–85 6.8 8.26
Total number N = 173859 n = 799
3.4. Dysmenorrhea and Other Functional Gastrointestinal
Disorders. A total of 45/57 (79%) of those who had func-
tional dyspepsia (FD) and 72/90 (80%) heartburn had
dysmenorrheal, and 88% of those who had diarrhea and or
constipation had dysmenorrhea (Figure 4). Altogether 39%
of those who had FD and 41% of those who had diarrhea
and/or constipation had severe or very severe dysmenorrhea.
There was a significant statistical diﬀerence (P < 0.01) of
orginally 
enrolled
responded 1996
were mailed a 
questionnaire 
2006
664 did not respond
81 were deceased
70 could not be traced 
to a current address
799 gave fully 
analysable data at 
baseline and 10 
years
376 did not respond
5 were unable to 
answer, 
Women,
Women,
n = 2000
n = 1336
n = 735
n = 156
n = 1185
n = 381
n = 452
Figure 2: Flow of study participants.
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Figure 3: Distribution of dysmenorrhea severity (1996, n = 254,
2006, n = 152).
Table 3: Women with menstruation and dysmenorrhea.
1996 2006
Total women 446 444
Women without menstruation 115 25.8% 239 53.8%
Women with menstruation 331 74.2% 205 46.2%
Women with dysmenorrhea 254 76.7% 152 74.1%
dysmenorrhea between those who had FD and those who did
not have FD. Those who had diarrhea and, or constipation
had proportionally higher prevalence of dysmenorrhea than
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Figure 4: Functional gastrointestinal disorders and dysmenorrhea
severity (2006, n = 152).
Table 4: Women with IBS according to Rome III and Manning and
dysmenorrhea.
1996 2006
Rome III
Dysmenorrhea 10.5% 25.7%
Without dysmenorrhea 5.3% 9.4%
Manning
Dysmenorrhea 41.5% 48.6%
Without dysmenorrhea 25.3% 33.3%
those who did not have diarrhea and or constipation (P <
0.01) (Figure 4).
3.5. Women with Dysmenorrhea in 1996 and after Menopause
2006, IBS, and Abdominal Pain Severity. In the year 1996,
overall 64 women experienced dysmenorrhea but did not
have periods in the year 2006. In the year 1996, 24/64 (38%)
of those had IBS according to the Manning criteria and 41%
in the year 2006 altogether. 6% experienced IBS according
to Rome III criteria in the year 1996 and 13% in the year
2006. Figure 5 shows the changes in abdominal pain severity
in women with dysmenorrhea in the year 1996 and after
menopause in the year 2006.
3.6. Transition between Disorders from the 1996 and 2006
Surveys. As described in the method section, the groups in
this analysis were defined as mutually exclusive, using the
symptom hierarchy so that each subject appears in only one
category for both the 1996 and 2006 surveys. There was a
“no symptoms” category for those who did not meet any
of the criteria applied for FGID. Due to the hierarchical
classification, only a few participants occurred in some
categories.
Transitions between disorders were explored in two ways,
for women with dysmenorrhea and for women without
dysmenorrhea (Figure 1). There was a substantial change
21%
68%
8%
3%
8%
66%
24%
2%
0
10
20
30
40
50
60
70
80
Minor Medium Severe Very severe
1996
2006
(%
)
Figure 5: Abdominal pain in women with dysmenorrhea 1996 and
after menopause 2006.
in numbers in all the categories between the two surveys.
The group “no symptoms” was the most common in both
transition models. For the women with dysmenorrheal, the
FD was the most stable one. A total of 17% moved into the
IBS group and 14% into the no symptom group. IBS was
stable in 30% cases, and the same number moved into the
FD group. One-fourth moved into the no symptom group.
There were only 4 women in the heartburn group of women
with dysmenorrhea. In women without dysmenorrheal, the
stability of symptoms was greater than that for those who
suﬀered from dysmenorrhea. 44% of the FD group was stable
between the initial and final surveys. One out of four moved
into the IBS group. The stability for the IBS group was 38%.
5/29 (17%) moved into the IBS group and 21% into the
no symptom group. The highest stability (42%) was in the
heartburn group.
The transitions were collected into six groups. Compar-
ison of the diﬀerences between women with and without
dysmenorrhea in those transition groups (Figure 6) showed
that the greatest diﬀerence was between the two groups of
women who remained asymptomatic. The women without
dysmenorrhea were twice more likely to remain asymp-
tomatic than the women with dysmenorrhea. The women
with dysmenorrhea were also more likely to have stable
symptoms at followup than women without dysmenorrhea.
The women with dysmenorrhea were twice more likely to
have increased symptoms than women without symptoms.
3.7. Birth Cohort Eﬀect of Dysmenorrhea. There was no
significant diﬀerence in prevalence between birth cohorts
in women with dysmenorrhea nor in women without
dysmenorrheal (Figure 7).
4. Discussion
The current study makes it possible for the first time to
follow up women with and without dysmenorrhea over a
ten-year period and to observe how the FGID symptoms are
associated with dysmenorrhea.
Every three out of four women with menstruation in
this study experience dysmenorrhea which is similar to other
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Figure 6: Six-group transition model, change from initial to the
final survey. Women with dysmenorrhea (n = 130) in the inner
circle and women without dysmenorrhea (n = 163) in the outer
circle.
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Figure 7: Birth cohort eﬀect on the prevalence (%) in 10 years.
studies. Analysis of women with dysmenorrhea showed that
they were more likely to have IBS, either based on the Rome
III criteria and/or the Manning criteria. The Manning criteria
were much more sensitive than the Rome criteria. There was
an increase in prevalence in dysmenorrhea over the ten-year
period for both women with IBS according to Rome III and
Manning, with more increase in dysmenorrhea in the Rome
III group.
A meta-analysis based on a small number of studies com-
pared gastrointestinal symptoms in pre- and postmenopause
women [15]. The authors concluded that there was insuﬃ-
cient evidence to determine the eﬀect of menopausal status
on IBS symptoms. The current study demonstrated an
increase in prevalence in women having IBS after menopause
using both IBS criteria. Increase in gastrointestinal symp-
toms around the time of menses and early menopause
occurs at times of declining or low ovarian hormones,
suggesting that estrogen and progesterone withdrawal may
contribute either directly or indirectly [16]. One study has
shown that gastrointestinal symptoms burden was higher in
postmenopausal women than in men, but these diﬀerences
mostly disappeared when controlled for age [7].
Women with dysmenorrhea report more gastrointestinal
symptoms prior to or concurrent with uterine cramping
pain at menses than women who are non-dysmenorrheic
[26]. Gastrointestinal symptoms tend to be increased across
all cycle phases in women with IBS compared to healthy
women, but both groups demonstrated a similar increase in
severity immediately prior to or at the onset of menses [27].
The current study compared the FGIDs and dysmenorrheal
severity and demonstrated that the great majority of women
with dysmenorrhea had other FGID symptoms than those
related to IBS. Women reported more severe abdominal pain
after menopause than before. One study has shown that
abdominal pain is the most disruptive IBS symptom [8].
The current study observed the transition between symp-
toms and revealed substantial diﬀerence between women
with and without dysmenorrhea. Women without dysmen-
orrhea remained more often asymptomatic than women
with dysmenorrhea. FGID symptoms were more stable in
10 years for women with dysmenorrheal, and they also
had more increase in symptoms than women without
dysmenorrhea. This demonstrated a diﬀerence between
those two groups of women. The prevalence of menstrually
related symptoms has been shown to be high and appears to
aﬀect bowel patterns [26]. A recent meta-analysis revealed a
significant menstrual cycle eﬀect for loose stools, bloating,
abdominal pain, stool frequency, and other changes in bowel
habit [15].
The strength of our study was the use of a stable
and homogeneous population. The sample was randomly
selected from the National Registry of Iceland and repre-
sented the nation as a whole in selected age groups. Only a
minority of IBS patients seek medical care, and population-
based studies are therefore essential for studying IBS. The
population of Iceland with approximately 300 thousand
inhabitants represents 1% of the whole population from all
around the country.
There are some limitations to our study. The subjects
were not specifically interviewed or examined to evaluate
the possibility of organic disease. However, the 10-year
(postal) followup went some way to making an organic cause
of symptoms unlikely. Information on women using the
contraceptive pill is lacking from this study, and this could
aﬀect the study. Also information on endometriosis and
other gynaecological problems is not addressed in this study
but could aﬀect the results. Furthermore, since the response
rate was 67% in 1996 and 69% in 2006, a drop-out bias
cannot be excluded. A similar mean age in the respondent
group and the nonrespondent group does not indicate an age
dropout bias in the study.
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